Paul A. Hargrave | |
---|---|
Born | 1938 |
Alma mater | Colgate University University of Minnesota |
Known for | Rhodopsin |
Scientific career | |
Fields | Biochemistry |
Institutions | California Institute of Technology Southern Illinois University University of Florida |
Paul Hargrave (born 1938) is an American biochemist whose laboratory work established key features of the structure of rhodopsin. [1] [2]
In 1970, Hargrave received a PhD from the University of Minnesota, where he studied with protein chemist Finn Wold. After post-doctoral work under William J. Dreyer at the California Institute of Technology, Hargrave joined the faculty at Southern Illinois University in 1973. [3]
In 1983, Hargrave and colleagues in his laboratory published the full amino acid sequence for rhodopsin, a photoreceptor protein, after having previously published partial sequences. [4] [5] [6] [7] The sequencing of rhodopsin was later described as a "monumental step" toward understanding the structure of rhodopsin. [8] [9] At the time, the purification of water-insoluble peptides was a challenge, and the Hargrave lab published several discoveries about how to manage them. [10]
Hargrave came to the University of Florida in 1984 as a Jules and Doris Stein Research to Prevent Blindness Professor [11] and in 1990 was named the Francis N. Bullard Professor and Eminent Scholar of Ophthalmology and Biochemistry at the University of Florida. [12] His work continued to explore the structure of rhodopsin, including developing a topographic model. [13] [14] He also pursued further research into the function of rhodopsin, including its role in visual disease such as retinitis pigmentosa and retinoblastoma. [15] [16]
In 1985, Hargrave chaired and secured funding for the first FASEB Science Research Conference on Biology and Chemistry of Vision, which has become a biennial conference. [17] [18]
In 2000, he received the Friedenwald Award of the Association for Research in Vision and Ophthalmology, which honors "outstanding research in the basic or clinical sciences as applied to ophthalmology." [19] [20]
Hargrave is a member of the 50 States Marathon Club, having completed a marathon in every state in the United States. [21]
He is the father of board game designer Elizabeth Hargrave. [22]
The retina is the innermost, light-sensitive layer of tissue of the eye of most vertebrates and some molluscs. The optics of the eye create a focused two-dimensional image of the visual world on the retina, which then processes that image within the retina and sends nerve impulses along the optic nerve to the visual cortex to create visual perception. The retina serves a function which is in many ways analogous to that of the film or image sensor in a camera.
Rhodopsin, also known as visual purple, is a protein encoded by the RHO gene and a G-protein-coupled receptor (GPCR). It is the opsin of the rod cells in the retina and a light-sensitive receptor protein that triggers visual phototransduction in rods. Rhodopsin mediates dim light vision and thus is extremely sensitive to light. When rhodopsin is exposed to light, it immediately photobleaches. In humans, it is regenerated fully in about 30 minutes, after which the rods are more sensitive. Defects in the rhodopsin gene cause eye diseases such as retinitis pigmentosa and congenital stationary night blindness.
The visual system is the physiological basis of visual perception. The system detects, transduces and interprets information concerning light within the visible range to construct an image and build a mental model of the surrounding environment. The visual system is associated with the eye and functionally divided into the optical system and the neural system.
Retinitis pigmentosa (RP) is a genetic disorder of the eyes that causes loss of vision. Symptoms include trouble seeing at night and decreasing peripheral vision. As peripheral vision worsens, people may experience "tunnel vision". Complete blindness is uncommon. Onset of symptoms is generally gradual and often begins in childhood.
Transducin (Gt) is a protein naturally expressed in vertebrate retina rods and cones and it is very important in vertebrate phototransduction. It is a type of heterotrimeric G-protein with different α subunits in rod and cone photoreceptors.
In visual physiology, adaptation is the ability of the retina of the eye to adjust to various levels of light. Natural night vision, or scotopic vision, is the ability to see under low-light conditions. In humans, rod cells are exclusively responsible for night vision as cone cells are only able to function at higher illumination levels. Night vision is of lower quality than day vision because it is limited in resolution and colors cannot be discerned; only shades of gray are seen. In order for humans to transition from day to night vision they must undergo a dark adaptation period of up to two hours in which each eye adjusts from a high to a low luminescence "setting", increasing sensitivity hugely, by many orders of magnitude. This adaptation period is different between rod and cone cells and results from the regeneration of photopigments to increase retinal sensitivity. Light adaptation, in contrast, works very quickly, within seconds.
The fovea centralis is a small, central pit composed of closely packed cones in the eye. It is located in the center of the macula lutea of the retina.
Retinal is a polyene chromophore. Retinal, bound to proteins called opsins, is the chemical basis of visual phototransduction, the light-detection stage of visual perception (vision).
Melanopsin is a type of photopigment belonging to a larger family of light-sensitive retinal proteins called opsins and encoded by the gene Opn4. In the mammalian retina, there are two additional categories of opsins, both involved in the formation of visual images: rhodopsin and photopsin in the rod and cone photoreceptor cells, respectively.
Animal opsins are G-protein-coupled receptors and a group of proteins made light-sensitive via a chromophore, typically retinal. When bound to retinal, opsins become retinylidene proteins, but are usually still called opsins regardless. Most prominently, they are found in photoreceptor cells of the retina. Five classical groups of opsins are involved in vision, mediating the conversion of a photon of light into an electrochemical signal, the first step in the visual transduction cascade. Another opsin found in the mammalian retina, melanopsin, is involved in circadian rhythms and pupillary reflex but not in vision. Humans have in total nine opsins. Beside vision and light perception, opsins may also sense temperature, sound, or chemicals.
The Stiles–Crawford effect is a property of the human eye that refers to the directional sensitivity of the cone photoreceptors.
Rhodopsin kinase is a serine/threonine-specific protein kinase involved in phototransduction. This enzyme catalyses the following chemical reaction:
Blue-sensitive opsin is a protein that in humans is encoded by the OPN1SW gene.
Green-sensitive opsin is a protein that in humans is encoded by the OPN1MW gene. OPN1MW2 is a similar opsin.
Guanylyl cyclase-activating protein 2 is an enzyme that in humans is encoded by the GUCA1B gene. Alternative names:
Krzysztof Palczewski is a Polish-American biochemist working at the University of California, Irvine.
Retinal degeneration is a retinopathy which consists in the deterioration of the retina caused by the progressive death of its cells. There are several reasons for retinal degeneration, including artery or vein occlusion, diabetic retinopathy, R.L.F./R.O.P., or disease. These may present in many different ways such as impaired vision, night blindness, retinal detachment, light sensitivity, tunnel vision, and loss of peripheral vision to total loss of vision. Of the retinal degenerative diseases retinitis pigmentosa (RP) is a very important example.
Aristostomias is a genus of barbeled dragonfishes native to the ocean depths in the Pacific, Atlantic and Indian oceans.
King-Wai Yau is a Chinese-born American neuroscientist and Professor of Neuroscience at Johns Hopkins University School of Medicine in Baltimore, Maryland.
Davida Young Teller was a professor in the Departments of Psychology and Physiology/Biophysics at the University of Washington, Seattle, Washington. She was a leader in the scientific study of infant visual development.